Really hoping more classmates begin to comment on posts earlier in the module which will allow the opportunity for more discussions.
Aside from that little bump in the road, a few things I've learned have been:
The FDA and the process' they go through before new drugs are released to the public which include:
1 - Preclinical research
2- Clinical research and development
3- Permission to market
4- Post marketing surveillance
There is a system called the FDA Adverse Event Reporting System (FAERS) that allows the public to voluntarily report any issues they have while taking medications.
Aside from the FAERS information, at the bottom of this web page there are also links for the National Library of Medicine, Medication Guides, and Postmarket Drug and Biological Safety Evaluations. I was very pleased to read through the FDA's website to see their initiatives and ways they keep in contact with the public about Drug Safety Information.
The book refers to the drug "diethylstilbestrol" (DES) on page 107 which was given to women to prevent miscarriage and was later discovered to cause cancer, birth defects, and other developmental abnormalities. It's unfortunate that something like this happened, but good that the FDA now has ways of patients being able to directly communicate if they're having health problems they believe could be caused by the drugs they're taking. More information can be found here at Cancer.Gov.
Two terms in this section I didn't know before are 1- Fast Tracking, which is a process designed to expedite the review of drugs to treat serious diseases and fill an unmet medical need, and 2- Priority Review, which is a designation given to drugs that offer major advances in treatment, or provide a treatment where no adequate therapy exists. These words helped me learn more about the process the FDA goes through when trying to approve a new drug to the market, which I found to be very interesting.
I also liked the discussion about whether or not a user is considered an addict or a criminal. It was interesting to read Brittany and Elizabeth's comments from the book and their linked websites to include this article which I particularly enjoyed.
I'd like to copy and post my original Seminar Post so I can refer back to it:
Drug Dependence and the Varieties of Addiction